RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nuoncology Labs Stock

Nuoncology Labs Market capitalization 2024

Nuoncology Labs Market capitalization

29.22 B USD

Ticker

NLAB

ISIN

US67057T1079

WKN

916415

In 2024, Nuoncology Labs's market cap stood at 29.22 B USD, a 473,886.59% increase from the 6.16 M USD market cap in the previous year.

The Nuoncology Labs Market capitalization history

YEARMarket Capitalization (undefined USD)
202129.22
20200
20190
19980.06

Nuoncology Labs Aktienanalyse

What does Nuoncology Labs do?

Nuoncology Labs Inc is a biotechnology company specialized in the development of novel cancer therapies. It was founded in 2015 by experienced scientists and entrepreneurs in the field of biotechnology. The main goal of Nuoncology Labs Inc is to develop better and more effective treatments for cancer. The company relies on innovative technologies and approaches to specifically target and combat cancer cells without damaging healthy tissue. An essential element of Nuoncology Labs Inc's business model is its close collaboration with leading research institutions worldwide. Through these partnerships, the company is able to access the latest knowledge and technologies in cancer research and utilize them for its own development of therapy approaches. Nuoncology Labs Inc is divided into various divisions, each focusing on specific aspects of cancer research and treatment. One important division is the exploration of novel drug candidates that target specific types and stages of cancer. The company utilizes state-of-the-art drug screening technology to identify and optimize promising candidates. Another division of Nuoncology Labs Inc focuses on the development of innovative diagnostic tools for cancer early detection and diagnosis. These tools incorporate advanced technologies such as liquid biopsy and imaging techniques to detect tumor cells and DNA alterations in the blood. Furthermore, a central focus of Nuoncology Labs Inc is the development of targeted therapies that aim at specific signaling pathways in cancer cells. The company utilizes antibodies and other targeted agents that target specific receptors or proteins in the cancer cells. An additional important product of Nuoncology Labs Inc is an innovative therapy system for immuno-oncology. This method aims to activate the body's own immune system specifically against cancer cells. The therapy concept is based on the application of specially designed immune stimulators that encourage the immune system to more effectively combat cancer cells. Overall, Nuoncology Labs Inc is one of the most promising companies in the field of biotechnology and cancer research. The company aims to develop innovative therapy approaches that can contribute to making cancer treatment more effective and tolerable. Nuoncology Labs Inc works closely with leading research institutions worldwide and utilizes state-of-the-art biotechnology technologies and methods. Nuoncology Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Nuoncology Labs's Market Capitalization

Nuoncology Labs's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Nuoncology Labs's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Nuoncology Labs's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Nuoncology Labs’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Nuoncology Labs stock

What is the current Nuoncology Labs market capitalization?

The current market capitalization of Nuoncology Labs is 29.22 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Nuoncology Labs.

How has the market capitalization of Nuoncology Labs developed in recent years?

The market capitalization of Nuoncology Labs has increased/decreased by 473,886.59% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Nuoncology Labs?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Nuoncology Labs?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Nuoncology Labs have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Nuoncology Labs pay?

Over the past 12 months, Nuoncology Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nuoncology Labs is expected to pay a dividend of 0 USD.

What is the dividend yield of Nuoncology Labs?

The current dividend yield of Nuoncology Labs is .

When does Nuoncology Labs pay dividends?

Nuoncology Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nuoncology Labs?

Nuoncology Labs paid dividends every year for the past 0 years.

What is the dividend of Nuoncology Labs?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nuoncology Labs located?

Nuoncology Labs is assigned to the '-' sector.

Wann musste ich die Aktien von Nuoncology Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nuoncology Labs from 11/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did Nuoncology Labs pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of Nuoncology Labs in the year 2023?

In the year 2023, Nuoncology Labs distributed 0 USD as dividends.

In which currency does Nuoncology Labs pay out the dividend?

The dividends of Nuoncology Labs are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nuoncology Labs

Our stock analysis for Nuoncology Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nuoncology Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.